The DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.
High Interstitial Fluid Pressure - an Obstacle in Cancer Therapy
Abstract
Many solid tumours show an increased interstitial fluid pressure (IFP), which forms a barrier to transcapillary transport. This barrier is an obstacle in tumour treatment, as it results in inefficient uptake of therapeutic agents. There are a number of factors that contribute to increased IFP in the tumour, such as vessel abnormalities, fibrosis and contraction of the interstitial matrix. Lowering the tumour IFP with specific signal-transduction antagonists might be a useful approach to improving anticancer drug efficacy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Necrotic tumor tissue does not present much harm to the host organism, but the hypoxic part of the tumor tissue and the hypoxic tumor cells are usually the major drivers of tumor progression [1–3].”
From Hypoxia Signaling in Cancer: From Basics to Clinical Practice (2021) · cites this paper as [3]
In the citing paper
“Cancer hypoxia and the induced adaptation mechanisms are two of the major causes of therapy resistance.”
From Hypoxia Signaling in Cancer: From Basics to Clinical Practice (2021) · cites this paper as [3]
Citations
Cites
Dvorak, H. F., Brown, L. F., Detmar, M. J., & Dvořàk, A. M. (1995) · Europe PMC (PubMed Central) · Cited by 3,100
Pericyte Loss and Microaneurysm Formation in PDGF-B-Deficient Mice
Lindahl, P., Johansson, B. R., Levéen, P., & Betsholtz, C. (1997) · Science · doi:10.1126/science.277.5323.242 · Cited by 2,226
Willett, C. G., Boucher, Y., di Tomaso, E., Duda, D. G., Munn, L. L., Tong, R. T., Chung, D. C., Sahani, D. V., Kalva, S. P., Kozin, S. V., et al. (2004) · Nature Medicine · doi:10.1038/nm988 · Cited by 1,985
The myofibroblast in wound healing and fibrocontractive diseases
Gabbiani, G. (2003) · The Journal of Pathology · doi:10.1002/path.1427 · Cited by 1,630
Transport of molecules in the tumor interstitium: a review.
Jain, R. K. (1987) · PubMed · Cited by 1,357
Angiopoietin-1 protects the adult vasculature against plasma leakage
Thurston, G., Rudge, J. S., Ioffe, E., Zhou, H., Ross, L. H., Croll, S. D., Glazer, N. L., Holash, J. A., McDonald, D. M., & Yancopoulos, G. D. (2000) · Nature Medicine · doi:10.1038/74725 · Cited by 1,314
Tong, R. T., Boucher, Y., Kozin, S. V., Winkler, F., Hicklin, D. J., & Jain, R. K. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0074 · Cited by 1,189
Barriers to Drug Delivery in Solid Tumors
Jain, R. K. (1994) · Scientific American · doi:10.1038/scientificamerican0794-58 · Cited by 1,074
Abnormalities in Pericytes on Blood Vessels and Endothelial Sprouts in Tumors
Morikawa, S., Bałuk, P., Kaidoh, T., Haskell, A., Jain, R. K., & McDonald, D. M. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64920-6 · Cited by 987
Lymphatic Metastasis in the Absence of Functional Intratumor Lymphatics
Padera, T. P., Kadambi, A., di Tomaso, E., Carreira, C. M., Brown, E. B., Boucher, Y., Choi, N. C., Mathisen, D. J., Wain, J. R., Mark, E. J., et al. (2002) · Science · doi:10.1126/science.1071420 · Cited by 982
Flagged first, then by citations
Research works printed but not linked: 1
- Kristensen, C. A. et al. Reduction of interstitial fluid pressure after TNF-α treatment of three human melanoma xenografts. Br. J. Cancer 74, 533–536 (1996). · DOI
Cited by
Sorted by citations
Items 201–300 of 1,003
Wang, G., Zhou, Z., Zhao, Z., Li, Q., Wu, Y., Yan, S., Shen, Y., & Huang, P. (2020) · ACS Nano · doi:10.1021/acsnano.0c00974 · Cited by 196
Hijacking the Neuronal NMDAR Signaling Circuit to Promote Tumor Growth and Invasion
Li, L., & Hanahan, D. (2013) · Cell · doi:10.1016/j.cell.2013.02.051 · Cited by 194
Targeted nanotechnology for cancer imaging
Toy, R., Bauer, L., Hoimes, C. J., Ghaghada, K. B., & Karathanasis, E. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.08.002 · Cited by 194
Intraperitoneal therapy for peritoneal tumors: biophysics and clinical evidence
Ceelen, W. P., & Flessner, M. F. (2009) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2009.217 · Cited by 192
Tumor Abnormality-Oriented Nanomedicine Design
Zhou, Q., Xiang, J., Qiu, N., Wang, Y., Piao, Y., Shao, S., Tang, J., Zhou, Z., & Shen, Y. (2023) · Chemical Reviews · doi:10.1021/acs.chemrev.3c00062 · Cited by 203
Extravasation of polymeric nanomedicines across tumor vasculature
Danquah, M. K., Zhang, X. A., & Mahato, R. I. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.11.005 · Cited by 193
Pathophysiological Basis for the Formation of the Tumor Microenvironment
Horsman, M. R., & Vaupel, P. W. (2016) · Frontiers in Oncology · doi:10.3389/fonc.2016.00066 · Cited by 192
Drug targeting to myofibroblasts: Implications for fibrosis and cancer
Yazdani, S., Bansal, R., & Prakash, J. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.07.010 · Cited by 191
Physiologically Based Pharmacokinetic Modeling of Nanoparticles
Yuan, D., He, H., Wu, Y., Fan, J., & Cao, Y. (2018) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2018.10.037 · Cited by 197
Cancer chemotherapy resistance: Mechanisms and recent breakthrough in targeted drug delivery
Davodabadi, F., Sajjadi, S. F., Sarhadi, M., Mirghasemi, S., Hazaveh, M. N., Khosravi, S., Andani, M. K., Cordani, M., Basiri, M., & Ghavami, S. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.176013 · Cited by 202
Hendry, S. A., Farnsworth, R. H., Solomon, B., Achen, M. G., Stacker, S. A., & Fox, S. B. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00621 · Cited by 188
Chen, Q., Chen, J., Liang, C., Feng, L., Dong, Z., Song, X., Song, G., & Liu, Z. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.11.006 · Cited by 188
Intratumoral Drug Delivery with Nanoparticulate Carriers
Holback, H., & Yeo, Y. (2011) · Pharmaceutical Research · doi:10.1007/s11095-010-0360-y · Cited by 189
Applications and challenges of ultra-small particle size nanoparticles in tumor therapy
Xu, J., Song, M., Zhou, F., Zheng, L., Huang, X., & Liu, K. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.12.028 · Cited by 188
Inhaled chemotherapy in lung cancer: future concept of nanomedicine
Zarogoulidis, P., Zarogoulidis, K., Domvri, Goldberg, Karamanos, N. K., Schmidt, F., & Chatzaki, Ε. (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s29997 · Cited by 189
Functionalized Nanoscale Micelles Improve Drug Delivery for Cancer Therapy in Vitro and in Vivo
Wei, T., Liu, J., Ma, H., Cheng, Q., Huang, Y., Zhao, J., Huo, S., Xue, X., Liang, Z., & Liang, X. (2013) · Nano Letters · doi:10.1021/nl400586t · Cited by 183
Oncolytic Viruses for Cancer Therapy: Overcoming the Obstacles
Wong, H. H., Lemoine, N. R., & Wang, Y. (2010) · Viruses · doi:10.3390/v2010078 · Cited by 182
Involvement of platelet‐derived growth factor ligands and receptors in tumorigenesis
Heldin, C. ‐., Lennartsson, J., & Westermark, B. (2018) · Journal of Internal Medicine · doi:10.1111/joim.12690 · Cited by 181
Self-citationThe Rise and Rise of Stealth Nanocarriers for Cancer Therapy: Passive Versus Active Targeting
Huynh, N. T., Roger, E., Lautram, N., Benoît, J., & Passirani, C. (2010) · Nanomedicine · doi:10.2217/nnm.10.113 · Cited by 183
Ultrasound-mediated nano drug delivery for treating cancer: Fundamental physics to future directions
Kashkooli, F. M., Jakhmola, A., Hornsby, T. K., Tavakkoli, J., & Kolios, M. C. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.02.009 · Cited by 184
Esquis, P., Consolo, D., Magnin, G., Pointaire, P., Moretto, P., Ynsa, M. D., Beltramo, J.-L., Drogoul, C., Simonet, M., Benoît, L., et al. (2006) · Annals of Surgery · doi:10.1097/01.sla.0000218089.61635.5f · Cited by 178
Wang, K., Zhang, X., Liu, Y., Liu, C., Jiang, B., & Jiang, Y. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.06.042 · Cited by 178
Heldin, C., & Lennartsson, J. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a009100 · Cited by 171
Self-citationDysregulated pH in Tumor Microenvironment Checkmates Cancer Therapy
Barar, J., & Omidi, Y. (2013) · Europe PMC (PubMed Central) · doi:10.5681/bi.2013.036 · Cited by 177
De Novo Design of a Tumor-Penetrating Peptide
Alberici, L., Roth, L., Sugahara, K. N., Agemy, L., Kotamraju, V. R., Teesalu, T., Bordignon, C., Traversari, C., Rizzardi, G., & Ruoslahti, E. I. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-1668 · Cited by 175
Huang, B.-W., & Gao, J.-Q. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.12.005 · Cited by 174
Sun, Y., & Davis, E. W. (2021) · Nanomaterials · doi:10.3390/nano11030746 · Cited by 183
Interstitial Pressure in Pancreatic Ductal Adenocarcinoma Is Dominated by a Gel-Fluid Phase
DuFort, C. C., DelGiorno, K. E., Carlson, M. A., Osgood, R. J., Zhao, C., Huang, Z., Thompson, C. B., Connor, R. J., Thanos, C. D., Scott Brockenbrough, J., et al. (2016) · Biophysical Journal · doi:10.1016/j.bpj.2016.03.040 · Cited by 171
Recent Preclinical and Clinical Progress in Liposomal Doxorubicin
Aloss, K., & Hamar, P. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15030893 · Cited by 171
Resistance to Chemotherapy in Cancer: A Complex and Integrated Cellular Response
Mellor, H. R., & Callaghan, R. (2008) · Pharmacology · doi:10.1159/000115967 · Cited by 170
The promise and challenges of combination therapies with antibody-drug conjugates in solid tumors
Wei, Q., Li, P., Yang, T. K., Zhu, J., Sun, L., Zhang, Z., Wang, L., Tian, X., Chen, J., Hu, C., et al. (2024) · Journal of Hematology & Oncology · doi:10.1186/s13045-023-01509-2 · Cited by 178
Eetezadi, S., Ekdawi, S. N., & Allen, C. J. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.10.001 · Cited by 169
Simulation of complex transport of nanoparticles around a tumor using tumor-microenvironment-on-chip
Kwak, B., Ozcelikkale, A., Shin, C. S., Park, K., & Han, B. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.08.027 · Cited by 165
Zhang, Z., Wang, H., Tan, T., Li, J., Wang, Z., & Li, Y. (2018) · Advanced Functional Materials · doi:10.1002/adfm.201801840 · Cited by 168
Press, M. F., & Lenz, H. (2007) · Drugs · doi:10.2165/00003495-200767140-00006 · Cited by 172
Fidoamore, A., Cristiano, L., Antonosante, A., d’Angelo, M., Giacomo, E. D., Astarita, C., Giordano, A., Ippoliti, R., Benedetti, E., & Cimini, A. (2016) · Stem Cells International · doi:10.1155/2016/6809105 · Cited by 175
Guo, S., Lin, C. M., Xu, Z., Miao, L., Wang, Y., & Huang, L. (2014) · ACS Nano · doi:10.1021/nn5010815 · Cited by 166
Rational Design of Biomaterials to Potentiate Cancer Thermal Therapy
Zhu, Y., Li, Q., Wang, C., Hao, Y., Yang, N., Chen, M., Ji, J., Feng, L., & Liu, Z. (2023) · Chemical Reviews · doi:10.1021/acs.chemrev.2c00822 · Cited by 163
Pericytes: gatekeepers in tumour cell metastasis?
Gerhardt, H., & Semb, H. (2007) · Journal of Molecular Medicine · doi:10.1007/s00109-007-0258-2 · Cited by 172
Targeting vascular and leukocyte communication in angiogenesis, inflammation and fibrosis
Kreuger, J., & Phillipson, M. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2015.2 · Cited by 160
Stimuli-Responsive “Cluster Bomb” for Programmed Tumor Therapy
Lei, Q., Wang, S., Hu, J., Lin, Y., Zhu, C., Rong, L., & Zhang, X. (2017) · ACS Nano · doi:10.1021/acsnano.7b03088 · Cited by 159
Nanoparticles containing insoluble drug for cancer therapy
Guo, S., & Huang, L. (2013) · Biotechnology Advances · doi:10.1016/j.biotechadv.2013.10.002 · Cited by 163
Interstitial Fluid Flow and Drug Delivery in Vascularized Tumors: A Computational Model
Welter, M., & Rieger, H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070395 · Cited by 159
Dissecting and rebuilding the glioblastoma microenvironment with engineered materials
Wolf, K. J., Chen, J., Coombes, J. D., Aghi, M. K., & Kumar, S. (2019) · Nature Reviews Materials · doi:10.1038/s41578-019-0135-y · Cited by 164
Zhong, X., Wang, X., Li, J., Hu, J., Cheng, L., & Yang, X. (2021) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2021.213828 · Cited by 159
The mechanical microenvironment in cancer: How physics affects tumours
Nagelkerke, A., Bussink, J., Rowan, A. E., & Span, P. N. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.09.001 · Cited by 158
Microenvironmental Metabolism Regulates Antitumor Immunity
Ngwa, V. M., Edwards, D. N., Philip, M., & Chen, J. (2019) · Cancer Research · doi:10.1158/0008-5472.can-19-0617 · Cited by 156
Carcinoma-Associated Fibroblasts Are a Promising Therapeutic Target
Togo, S., Polanska, U. M., Horimoto, Y., & Orimo, A. (2013) · Cancers · doi:10.3390/cancers5010149 · Cited by 162
Waite, C. L., & Roth, C. M. (2012) · Critical Reviews in Biomedical Engineering · doi:10.1615/critrevbiomedeng.v40.i1.20 · Cited by 160
Cell–cell and cell–matrix dynamics in intraperitoneal cancer metastasis
Sodek, K. L., Murphy, K., Brown, T. J., & Ringuette, M. J. (2012) · Cancer and Metastasis Reviews · doi:10.1007/s10555-012-9351-2 · Cited by 157
Nanotechnology for breast cancer therapy
Tanaka, T., Decuzzi, P., Cristofanilli, M., Sakamoto, J. H., Tasciotti, E., Robertson, F. M., & Mauro Ferrari, B. (2008) · Biomedical Microdevices · doi:10.1007/s10544-008-9209-0 · Cited by 159
Liu, Y., Zhang, D., Qiao, Z., Qi, G., Liang, X., Chen, X., & Wang, H. (2015) · Advanced Materials · doi:10.1002/adma.201501502 · Cited by 155
Multiscale Modelling of Fluid and Drug Transport in Vascular Tumours
Shipley, R. J., & Chapman, S. J. (2010) · Bulletin of Mathematical Biology · doi:10.1007/s11538-010-9504-9 · Cited by 152
Rickard, B. P., Conrad, C., Sorrin, A. J., Ruhi, M. K., Reader, J. C., Huang, S. A., Franco, W., Scarcelli, G., Polacheck, W. J., Roque, D. M., et al. (2021) · Cancers · doi:10.3390/cancers13174318 · Cited by 163
Role of Lymphangiogenesis in Cancer
Sundar, S. S., & Ganesan, T. S. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.1092 · Cited by 155
Radiation effects on the tumor microenvironment: Implications for nanomedicine delivery
Stapleton, S., Jaffray, D. A., & Milosevic, M. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.05.021 · Cited by 158
Mechanical Forces in Tumor Angiogenesis
Zanotelli, M. R., & Reinhart‐King, C. A. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-95294-9_6 · Cited by 165
Peptide-Mediated Targeting to Tumor Blood Vessels of Lung Cancer for Drug Delivery
Lee, T.-Y., Lin, C., Kuo, S.-Y., Chang, D.-K., & Wu, H. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-2233 · Cited by 155
Sung, S., Su, Y., Cheng, W., Hu, P.-F., Chiang, C., Chen, W., & Hu, S. (2018) · Nano Letters · doi:10.1021/acs.nanolett.8b03249 · Cited by 154
Releasing Pressure in Tumors: What Do We Know So Far and Where Do We Go from Here? A Review
Ariffin, A. B., Forde, P. F., Jahangeer, S. M., Soden, D. M., & Hinchion, J. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-3696 · Cited by 152
Overcoming key biological barriers to cancer drug delivery and efficacy
Kim, S. M., Faix, P. H., & Schnitzer, J. E. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.09.016 · Cited by 156
Hyperthermia can alter tumor physiology and improve chemo- and radio-therapy efficacy
Dunne, M., Regenold, M., & Allen, C. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.07.007 · Cited by 150
Exploiting macrophages as targeted carrier to guide nanoparticles into glioma
Pang, L., Qin, J., Han, L., Zhao, W., Liang, J., Xie, Z., Yang, P., & Wang, J. (2016) · Oncotarget · doi:10.18632/oncotarget.9464 · Cited by 151
2D Layered Double Hydroxide Nanoparticles: Recent Progress toward Preclinical/Clinical Nanomedicine
Cao, Z., Li, B., Sun, L., Li, L., Xu, Z. P., & Gu, Z. (2019) · Small Methods · doi:10.1002/smtd.201900343 · Cited by 151
Remodeling Tumor Vasculature to Enhance Delivery of Intermediate-Sized Nanoparticles
Jiang, W., Huang, Y., An, Y., & Kim, B. Y. S. (2015) · ACS Nano · doi:10.1021/acsnano.5b02028 · Cited by 151
iRGD Peptide as a Tumor-Penetrating Enhancer for Tumor-Targeted Drug Delivery
Kang, S., Lee, S., & Park, S. (2020) · Polymers · doi:10.3390/polym12091906 · Cited by 139
Generation of an in vitro 3D PDAC stroma rich spheroid model
Ware, M. J., Keshishian, V., Law, J. J., Ho, J. C., Favela, C. A., Rees, P. C. T., Smith, B., Sayeeduddin, M., Hwang, R. F., Rajapakshe, K., et al. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.08.041 · Cited by 146
Interstitial Fluid Pressure in Tumors: Therapeutic Barrier and Biomarker of Angiogenesis
Lunt, S. J., Fyles, A., Hill, R. P., & Milosevic, M. (2008) · Future Oncology · doi:10.2217/14796694.4.6.793 · Cited by 147
DuFort, C. C., DelGiorno, K. E., & Hingorani, S. R. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.03.040 · Cited by 144
Flow-induced stress on adherent cells in microfluidic devices
Shemesh, J., Jalilian, I., Shi, A., Heng Yeoh, G., Knothe Tate, M. L., & Ebrahimi Warkiani, M. (2015) · Lab on a Chip · doi:10.1039/c5lc00633c · Cited by 144
Yang, H., Guan, L., Li, S., Jiang, Y. Y., Xiong, N., Li, L., Wu, C., Zeng, H., & Liu, Y. (2016) · Oncotarget · doi:10.18632/oncotarget.7583 · Cited by 144
Harder, B. G., Blomquist, M. R., Wang, J., Kim, A. J., Woodworth, G. F., Winkles, J. A., Loftus, J. C., & Tran, N. L. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00462 · Cited by 153
The progress and perspective of strategies to improve tumor penetration of nanomedicines
Hu, J., Yuan, X., Wang, F., Gao, H., Liu, X., & Zhang, W. (2020) · Chinese Chemical Letters · doi:10.1016/j.cclet.2020.11.006 · Cited by 144
Sacchi, A., Gasparri, A. M., Gallo‐Stampino, C., Toma, S., Curnis, F., & Corti, A. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1147 · Cited by 144
Lee, J., Chung, S., Cho, H., & Kim, D. (2015) · Advanced Functional Materials · doi:10.1002/adfm.201500680 · Cited by 142
Hypoxia-induced metabolic shifts in cancer cells: Moving beyond the Warburg effect
Weljie, A. M., & Jirik, F. R. (2010) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2010.08.009 · Cited by 143
Sodium homeostasis in the tumour microenvironment
Leslie, T. K., James, A. D., Zaccagna, F., Grist, J. T., Deen, S. S., Kennerley, A. J., Riemer, F., Kaggie, J. D., Gallagher, F. A., Gilbert, F. J., et al. (2019) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2019.07.001 · Cited by 141
Rofstad, E. K., Galappathi, K., & Mathiesen, B. S. (2014) · Neoplasia · doi:10.1016/j.neo.2014.07.003 · Cited by 139
Combination antitumor therapy with targeted dual-nanomedicines
Dai, W., Wang, X., Song, G., Liu, T., He, B., Zhang, H., Wang, X., & Zhang, Q. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.03.001 · Cited by 139
Tumour microenvironment responsive nanoconstructs for cancer theranostic
Gulzar, A., Xu, J., Wang, C., He, F., Yang, D., Gai, S., Yang, P., Lin, J., Jin, D., & Xing, B. (2019) · Nano Today · doi:10.1016/j.nantod.2019.03.007 · Cited by 141
Active Transportation of Liposome Enhances Tumor Accumulation, Penetration, and Therapeutic Efficacy
Wang, G., Wu, B., Li, Q., Chen, S., Jin, X., Liu, Y., Zhou, Z., Shen, Y., & Huang, P. (2020) · Small · doi:10.1002/smll.202004172 · Cited by 138
Chang, D.-K., Lin, C., Wu, C., & Wu, H. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004171 · Cited by 137
Layered Double Hydroxides: Recent Progress and Promising Perspectives Toward Biomedical Applications
Li, L., Soyhan, I., Warszawik, E. M., & van Rijn, P. (2024) · Advanced Science · doi:10.1002/advs.202306035 · Cited by 143
Tumor-Penetrating iRGD Peptide Inhibits Metastasis
Sugahara, K. N., Braun, G. B., de Mendoza, T. H., Kotamraju, V. R., French, R. P., Lowy, A. M., Teesalu, T., & Ruoslahti, E. I. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-14-0366 · Cited by 137
Biomimetic hydrogel supports initiation and growth of patient-derived breast tumor organoids
Prince, E., Cruickshank, J., Ba-Alawi, W., Hodgson, K., Haight, J., Tobin, C., Wakeman, A., Avoulov, A., Topolskaia, V., Elliott, M. J., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28788-6 · Cited by 135
Tumor organoid models in precision medicine and investigating cancer-stromal interactions
Xu, R., Zhou, X., Wang, S., & Trinkle, C. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107668 · Cited by 134
Gu, G., Gao, X., Hu, Q., Kang, T., Liu, Z., Jiang, M., Miao, D., Song, Q., Yao, L., Tu, Y., et al. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.03.036 · Cited by 138
Macrophages are important mediators of either tumor- or inflammation-induced lymphangiogenesis
Ji, R. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0848-6 · Cited by 135
Real-time Imaging of Tumor-Cell Shedding and Trafficking in Lymphatic Channels
Hayashi, K., Jiang, P., Yamauchi, K., Yamamoto, N., Tsuchiya, H., Tomita, K., Moossa, A. R., Bouvet, M., & Hoffman, R. M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1237 · Cited by 134
Peptide-conjugated nanoparticles for targeted imaging and therapy of prostate cancer
Yeh, C.-Y., Hsiao, J., Wang, Y., Lan, C.-H., & Wu, H. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.05.015 · Cited by 131
Timbie, K. F., Afzal, U., Date, A. A., Zhang, C., Song, J. S., Miller, G. W., Suk, J. S., Hanes, J. S., & Price, R. J. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.03.017 · Cited by 133
Li, Y., Chen, M., Hu, J., Sheng, R., Lin, Q., He, X., & Guo, M. (2020) · Cell stem cell · doi:10.1016/j.stem.2020.09.012 · Cited by 132
Perspectives for Improving the Tumor Targeting of Nanomedicine via the EPR Effect in Clinical Tumors
Kim, J., Cho, H., Lim, D., Joo, M. K., & Kim, K. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241210082 · Cited by 149
Sen, A., Capitano, M. L., Spernyak, J. A., Schueckler, J. T., Thomas, S., Singh, A. K., Evans, S. S., Hylander, B. L., & Repasky, E. A. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-4482 · Cited by 132
A Mechanistic Perspective of Monoclonal Antibodies in Cancer Therapy Beyond Target-Related Effects
Strome, S. E., Sausville, E. A., & Mann, D. L. (2007) · The Oncologist · doi:10.1634/theoncologist.12-9-1084 · Cited by 133
Transcytosis of Nanomedicine for Tumor Penetration
Liu, Y., Huo, Y., Yao, L., Xu, Y., Meng, F., Li, H., Sun, K., Zhou, G., Kohane, D. S., & Tao, K. (2019) · Nano Letters · doi:10.1021/acs.nanolett.9b03211 · Cited by 129
Lu, R., Chang, Y., Chen, M., & Wu, H. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2010.12.061 · Cited by 127
Lai, J., Deng, G., Sun, Z., Peng, X., Li, J., Gong, P., Zhang, P., & Cai, L. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.04.026 · Cited by 129
MBene as a Theranostic Nanoplatform for Photocontrolled Intratumoral Retention and Drug Release
Chen, D., Jin, Z., Zhao, B., Wang, Y., & He, Q. (2021) · Advanced Materials · doi:10.1002/adma.202008089 · Cited by 127
Vickerman, V., & Kamm, R. D. (2012) · Integrative Biology · doi:10.1039/c2ib00184e · Cited by 126
Metadata
- Authors
- Heldin, C.-H., Rubin, K., Pietras, K., & Östman, A.
- Affiliations
- Ludwig Cancer Research (SE)
- Uppsala University (SE)
- University of California, San Francisco (US)
- Karolinska Institutet (SE)
- Corresponding author
- Heldin, Carl-Henrik
- Venue
- Nature reviews. Cancer
- Published
- 2004-10
- Volume
- 4
- Issue
- 10
- Pages
- 806-813
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2028156849
- Cited by
- 2,222
- References
- 78
- Citations by year
- 2026: 121 · 2025: 110 · 2024: 118 · 2023: 119 · 2022: 163 · 2021: 158 · 2020: 158 · 2019: 123 · 2018: 123 · 2017: 135 · 2016: 133 · 2015: 110 · 2014: 117 · 2013: 124 · 2012: 87
- FWCI
- 3.19
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Cancerfonden
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular Mechanics and Interactions
- Health Sciences › Medicine › Oncology › Lymphatic System and Diseases
- Keywords
- interstitial fluid pressure, solid tumors, tumor microenvironment, tumor fibrosis, anticancer drug delivery, tumor hypoxia
- MeSH terms
- Alprostadil, Animals, Antineoplastic Agents, Biological Transport, Bradykinin, Humans, Hyaluronoglucosaminidase, Hydrostatic Pressure, Neoplasms, Niacinamide, Platelet-Derived Growth Factor, Tumor Necrosis Factor-alpha, Signal Transduction, Transforming Growth Factor beta, Vascular Endothelial Growth Factor A, Extracellular Fluid, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review